Autophagy is a cell biological pathway affecting immune responses. In vitro, autophagy acts as a cell-autonomous defense against Mycobacterium tuberculosis, but its role in vivo is unknown. Here we show that autophagy plays a dual role against tuberculosis: antibacterial and anti-inflammatory. M. tuberculosis infection of Atg5 fl/fl LysM-Cre + mice relative to autophagy-proficient littermates resulted in increased bacillary burden and excessive pulmonary inflammation characterized by neutrophil infiltration and IL-17 response with increased IL-1α levels. Macrophages from uninfected Atg5 fl/fl LysM-Cre + mice displayed a cell-autonomous IL-1α hypersecretion phenotype, whereas T cells showed propensity toward IL-17 polarization during nonspecific activation or upon restimulation with mycobacterial antigens. Thus, autophagy acts in vivo by suppressing both M. tuberculosis growth and damaging inflammation.
Autophagy is a cell biological pathway affecting immune responses.
In vitro, autophagy acts as a cell-autonomous defense against Mycobacterium tuberculosis, but its role in vivo is unknown. Here we show that autophagy plays a dual role against tuberculosis: antibacterial and anti-inflammatory. M. tuberculosis infection of Atg5 fl/fl LysM-Cre + mice relative to autophagy-proficient littermates resulted in increased bacillary burden and excessive pulmonary inflammation characterized by neutrophil infiltration and IL-17 response with increased IL-1α levels. Macrophages from uninfected Atg5
fl/fl LysM-Cre + mice displayed a cell-autonomous IL-1α hypersecretion phenotype, whereas T cells showed propensity toward IL-17 polarization during nonspecific activation or upon restimulation with mycobacterial antigens. Thus, autophagy acts in vivo by suppressing both M. tuberculosis growth and damaging inflammation.
Th17 response | calpain | inflammasome | macrophage A utophagy is a fundamental cell biological process (1) with impact on aging, development, cancer, neurodegeneration, myodegeneration, metabolic disorders (2), idiopathic inflammatory diseases, and infection and immunity (3) . Much of the physiological effects of autophagy are the result of degradative activities of autophagy (1) , although biogenesis and secretory roles (4-6) of autophagy are beginning to be recognized (7) . The execution of autophagy depends on factors collectively termed "Atg proteins," such as Atg5 (1) and Beclin 1 (Atg6) (8) , whereas regulation of autophagy responds to various inputs via mammalian target of rapamycin (mTOR), including the presence of microbes (9) , the TAB2/3-TAK1-IKK signaling axis (10) , and processes downstream of pattern-recognition receptors and immune cytokine activation (3, (11) (12) (13) .
In the context of its immunological functions, autophagy acts in four principal ways (14) . (i) Autophagy cooperates with conventional pattern-recognition receptors (PRRs), such as Toll-like receptors, RIG-I-like receptors (RLRs), and NOD-like receptors, and acts as both a regulator (11, 12, 15, 16) and an effector of PRR signaling (17) (18) (19) . (ii) Autophagy affects the presentation of cytosolic antigens in the context of MHC II molecules (20) in T-cell development, differentiation, polarization, and homeostasis (21, 22) . (iii) Most recently, autophagy has been shown to contribute to both the negative (6, 7, (23) (24) (25) and positive (6, 7) regulation of unconventional secretion of the leaderless cytosolic proteins known as "alarmins," such as IL-1β and HMGB1. (iv) Autophagy can capture and eliminate intracellular microbes, including Mycobacterium tuberculosis (17, (26) (27) (28) (29) , which was one of the first two bacterial species (26, 30) to be recognized as targets for autophagic removal. This activity recently has been shown to depend on the recognition and capture of microbes by adaptors that represent a specialized subset of PRRs termed "sequestosome-like receptors" (SLRs) (31) .
M. tuberculosis is one of the first microbes recognized as being subject to elimination by immunological autophagy by murine and human macrophages in ex vivo systems (17, 22, 26, 27, 29) . Although it has been shown that macrophages from Atg5 fl/fl LysM-Cre + mice defective for autophagy in myeloid lineage fail to control M. tuberculosis H37Rv (32) , the in vivo role of autophagy in controlling M. tuberculosis has not been reported. Given the compelling reasons for testing whether autophagy is involved in the control of M. tuberculosis in vivo, we used a mouse model of tuberculosis with transgenic mice deficient in Atg5 in the myeloid lineage, including macrophages, a cell type parasitized by M. tuberculosis (33) . We demonstrate that autophagy controls tuberculosis infection in vivo and show a parallel role of autophagy in preventing excessive inflammatory reactions in the host.
Results
Autophagy Protects Mice from M. tuberculosis. The in vivo role of autophagy was investigated by selective genetic deletion of Atg5 in myeloid cells (which include macrophages and granulocytes); macrophages were of principal interest as the cells both successfully parasitized by intracellular M. tuberculosis (33) and targeted by protective immune responses. We used the previously reported conditional gene-knockout mouse model Atg5 fl/fl LysM-Cre + with Atg5 deletion in myeloid lineage (34 (Fig. 1D , i-iv) with an increase in the percent of involved lung area and total lung weight (SI Appendix, Fig. S1 A and B) and a differential increase in polymorphonuclear These authors contributed equally to this work. (PMN) leukocytes (Ly6G + ) (SI Appendix, Fig. S1 C-E). Acidfast bacilli per unit area were twofold higher in lung sections from Atg5 fl/fl LysM-Cre + mice than in lung sections from Atg5 fl/fl LysM-Cre − mice (Fig. 1D , v and vi). In keeping with the well-known general resistance of mice to tuberculosis, neither group of mice succumbed to the infection in short term (36 d LysM-Cre − littermates, starting 3 wk postinfection ( Fig. 1 E and F) . These data indicate that Atg5 fl/fl LysM-Cre + mice are more susceptible to M. tuberculosis infection over a range of infectious doses and also suggest that the differences in lung pathology exceed the observed differences in bacterial burden. LysM-Cre + mice as compared with -Cre − animals, but the absolute levels of IL-1β were much lower than the levels of IL-1α (SI Appendix, Fig. S2 G and H) .
The uninfected Atg5 fl/fl LysM-Cre + and -Cre − animals did not display signs of morbidity, overt disease, or discomfort per standards of veterinary care or differences in mortality. However, IL-1α was detectable at low basal levels even in the lungs of uninfected mice and was higher in Atg5 fl/fl LysM-Cre + mice than in Atg5 fl/fl LysM-Cre − littermates (SI Appendix, Fig. S3A ). Increased basal levels of CXCL1 were observed in the lungs of Atg5 fl/fl LysM-Cre + mice compared to lungs from -Cre − mice (SI Appendix, Fig. S3B ), whereas IL-12p70 levels were equal in both uninfected animal groups (SI Appendix, Fig. S3C ). IL-1β and IL-17 were below the limits of detection in the lungs of both uninfected Atg5 fl/fl LysM-Cre + and uninfected -Cre − mice (SI Appendix, Fig. S3 D and E) . Thus, some components of the cytokine profiles seen during infection (notably IL-1α and CXCL1) were present at low levels in uninfected animals.
In When not otherwise specified, data are shown as mean ± SE; *P < 0.05, **P < 0.01,
lineage-negative CD3
− CD19 − ) were detected in the lungs and bone marrow (SI Appendix, Fig. S3 F and G) Fig. S3I ). This increase in total PMN number was observed only in the lungs, because bone marrow PMN numbers were comparable in the two groups of mice (SI Appendix, Fig. S3J Cells. The proinflammatory properties described above were investigated next using immunologically active components of M. tuberculosis. We used a mixture of five well-defined M. tuberculosis protein antigens (DnaK, GroEL, Rv009, Rv0569, and Rv0685) collectively referred to as "synthetic PPD" (38) in reference to the purified protein derivative (PPD) used clinically as a tuberculin skin test for evidence of recent tuberculosis infection or bacillus Calmette-Guérin vaccination. The synthetic PPD reproduces the anatomical and molecular properties of the tuberculin skin test but eliminates false-positive inflammatory reactions (seen in uninfected hosts) caused by the contaminating lipoglycans and carbohydrates resident in conventional PPD (38) . Atg5 fl/fl LysM-Cre + and -Cre − mice were injected peritoneally with live Mycobacterium bovis bacillus Calmette-Guérin, and the quality of their immune responses was evaluated 3 wk later. Mice were injected with the synthetic PPD or PBS (as control) in the hind footpad, and delayed-type hypersensitivity (DTH) induration was measured at 0, 2, 24, and 48 h postinoculation (Fig. 4A ). No differences between the autophagycompetent and mutant mice were observed at the 24 and 48 h time points. However, when splenocytes from the animals inoculated with bacillus Calmette-Guérin were restimulated ex vivo with synthetic PPD, IL-17A was detected at significantly higher levels in splenocytes from Atg5 fl/fl LysM-Cre + animals ( Fig. 4B ), but no differences were observed for typical Th1 and Th2 cytokine signatures ( entiation ex vivo, IL-1α showed a capacity to promote Th17 polarization (SI Appendix, Fig. S4 C-F) .
In vitro-activated Atg5 fl/fl LysM-Cre + bone marrow macrophages (BMM) recapitulated the in vivo pattern of elevated secretion of IL-1α (along with CXCL1 and IL-12p70) relative to Atg5 fl/fl LysM-Cre − BMM (Fig. 5 A-C) . The CXCL1 phenotype was likely secondary to IL-1 increase, because IL-1 receptor antagonist (IL-1RA) lowered CXCL1 levels (Fig. 5D ). Differential release of IL-1α, which is a cytosolic protein, was not caused by changes in cell death or increased membrane permeability, because in vitro-activated BMM from Atg5 fl/fl LysM-Cre + and Atg5 fl/fl LysM-Cre − mice showed no difference in staining with 7-aminoactinomycin D (7-AAD) (Fig. 5E ). These experiments, and additional data showing elevated secretion of IL-1α in the lungs of uninfected Atg5 fl/fl LysM-Cre + animals [whereas IL-12p70 and IL-1β were below detection levels in these mice (SI Appendix, Fig. S3 D and E) ], singled out IL-1α as a potential pivot of the proinflammatory pathology observed with Atg5 fl/fl LysM-Cre + mice in the tuberculosis model. We could not test this conclusion in vivo, however, because IL-1α also plays a critical protective role against bacterial burden, as recently shown in IL-1α-knockout mice (39) .
Cellular Mechanism for Increased Secretion of IL-1α by AutophagyDeficient Macrophages Is Inflammasome Independent. We wanted to understand the cellular mechanism of the IL-1α hypersecretion phenotype in Atg5 fl/fl LysM-Cre + macrophages. Autophagy was confirmed as a negative regulator of IL-1α release by pharmacologically manipulating autophagy in Atg5 fl/fl LysMCre − BMM. The induction of autophagy with rapamycin in autophagy-competent macrophages reduced the amount of IL-1α being secreted (Fig. 5F ), paralleling the effects on IL-1β (SI Appendix, Fig. S5A ), a cytokine whose secretion we (6) and others (23, 24) previously have reported to be affected by autophagy. Conversely, when Atg5 fl/fl LysM-Cre − BMM were treated with 3-methyladenine (3MA), an inhibitor of autophagosome formation, the levels of IL-1α were increased significantly (Fig. 5E) . As a control, autophagy-deficient Atg5 fl/fl LysM-Cre + BMM showed no response in IL-1α secretion to these pharmacological agents (SI Appendix, Fig. S5B ). An effect similar to 3MA was observed upon treatment of Atg5 fl/fl LysM-Cre − BMM with bafilomycin A1 (Baf A1), an inhibitor of autophagic flux (Fig. 5G) .
We next considered multiple levels at which absence of autophagy could result in elevated IL-1α secretion. The autophagic adaptor protein p62, which is consumed during autophagy (40) and is the founding member of the SLR family of PRR (31) , also functions prominently in innate immunity signaling (41) . It accumulates in the absence of autophagy and has been shown to perturb NF-κB responses and cytokine secretion (41, 42) . Because IL-1α expression is controlled by NF-κB (43), we tested whether p62-mediated NF-κB activation could be the cause of elevated IL-1α expression. However, knocking down p62 via siRNA in Atg5 fl/fl LysM-Cre + BMM (SI Appendix, Fig. S6A ) did not abrogate the elevated IL-1α secretion by these cells (SI Appendix, Fig. S6B ). Knocking down Atg5 in BMM from p62 −/− knockout mice still caused more (albeit less pronounced, because of residual Atg5 levels) IL-1α secretion than in the scrambled siRNA control (SI Appendix, Fig. S6C ). Finally, no increase in IL-1α mRNA levels was detected in Atg5 fl/fl LysMCre + BMM relative to Atg5 fl/fl LysM-Cre − BMM (SI Appendix, Fig. S6D ). Thus, the p62-NF-κB axis does not contribute to the IL-1α phenotype in Atg5-deficient cells, and IL-1α expression is not transcriptionally activated in Atg5 fl/fl LysM-Cre + macrophages. We next considered whether IL-1α was a direct target for removal by autophagic organelles. Endogenous LC3 and IL-1α did not colocalize (SI Appendix, Fig. S6E , Left and Center Images), displayed a negative Pearson's colocalization coefficient even upon treatment with Baf A1 (SI Appendix, Fig. S6E , Graph), and showed complete separation of respective profiles (SI Appendix, Fig. S6E , Right Image). Thus, IL-1α is unlikely to be a direct substrate for autophagic elimination.
Pathways leading to IL-1α secretion have been reported to use inflammasome components (44, 45) although, unlike IL-1β, intracellular IL-1α is not an enzymatic substrate for caspase 1. Fig. S6H ). In keeping with the potential role for inflammasome and caspase 1 in IL-1α release (44, 45) , adding silica to macrophages increased their IL-1α output (Fig. 5H) . However, both the basal and inflammasome agonist (silica)-induced levels of IL-1α released from macrophages were increased in Atg5 fl/fl LysM-Cre + BMM. Furthermore, when we tested whether this release was caspase 1 dependent, neither the enzymatic inhibitor of caspase 1, YVAD (Fig. 5I) , nor caspase 1 knockdown (Fig. 5 J-L) decreased relative IL-1α output. We next tested whether the elevated IL-1α secretion by Atg5 fl/fl LysM-Cre + BMM was dependent on other inflammasome components. Knocking down the key inflammasome constituents ASC and NLRP3 did not diminish the IL-1α output of Atg5 fl/fl LysM-Cre + cells (Fig. 5M) . These observations, although surprising, are in agreement with the recent report of an inflammasome/caspase 1-independent pathway for IL-1α secretion (46) and show that, although the inflammasome is activated in Atg5 fl/fl LysM-Cre + BMM, it is not responsible for the increase in IL-1α output. (Fig. 5O ). In keeping with the previous reports (23), APDC also inhibited excessive IL-1β release from Atg5 fl/fl LysM-Cre + BMM (Fig. 5P) . Thus, ROS are mediators leading to hypersecretion of both IL-1α and IL-1β by autophagydeficient cells, but the machinery downstream of ROS differs for the two cytokines, because IL-1β depends on the inflammasome (23), whereas IL-1α, as shown here, does not.
ROS can lead to calpain activation (47, 48) , although this pathway has not been implicated previously in inflammation. We used ALLN, a calpain inhibitor, to test whether calpain is in- 
(B-E) Cytokine production by splenocytes from Atg5
fl/fl LysM-Cre − and -Cre + mice (day 23 after peritoneal injection of bacillus Calmette-Guérin) restimulated for 3 d ex vivo with synthetic PPD. All mice were 10-12 wk of age at the onset of the experiment. Data are shown as mean ± SE; **P < 0.01, † P > 0.05 (t test; n ≥ 3). 
(R) IL-1α release from LPS-and IFN-γ-stimulated Atg5
fl/fl LysM-Cre − BMM and Atg5 fl/fl LysM-Cre + BMM knocked down with siRNA for Calpain S1. Data are shown as mean ± SE; *P < 0.05, **P < 0.01, † P > 0.05 (t test; n ≥ 3).
volved in the IL-1α hypersecretion phenotype of Atg5 fl/fl LysMCre + cells. ALLN treatment of Atg5 fl/fl LysM-Cre + completely inhibited the excess IL-1α production, normalizing its output to the levels seen with Atg5 fl/fl LysM-Cre − cells (Fig. 5Q ). An siRNA knockdown of the common calpain regulatory (small) subunit Capns1, which forms heterodimers with and is required for function of the conventional murine calpains Capn1 and Capn2 (49), abrogated IL-1α hypersecretion (Fig. 5R) . We also considered the possibility that calpain may be a target for degradation by autophagy; however, calpain levels were not different in Atg5
fl/fl LysM-Cre + vs. -Cre − cells (SI Appendix, Fig. S6F ), and calpain did not colocalize with autophagic organelles (SI Appendix, Fig. S6G ). We conclude that the increase in IL-1α associated with the Atg5 defect in macrophages is caused by elevated ROS and depends not on the absolute levels of calpain but on its activation downstream of ROS, thus defining an additional proinflammatory pathway downstream of autophagy.
Discussion
This work demonstrates the in vivo role of autophagy in protection against tuberculosis. Along with the previous in vitro studies addressing the antimycobacterial effector mechanisms of autophagy (17, 22, 26-29, 50, 51) , these results establish that autophagy is a bona fide barrier again tuberculosis. Autophagy protects against tissue necrosis and lung pathology, the hallmarks of active tuberculosis. This effect is not a simple consequence of increased bacillary loads but is compounded by the cell-autonomous action of autophagy in macrophage-driven inflammatory processes. Autophagy-deficient macrophages release excessive amounts of inflammatory mediators, such as IL-1α, even in the absence of infection. A model emerges whereby these mediators, when in excess, pivot inflammation with features of a Th17 response, neutrophilic infiltration, tissue necrosis, and organ damage, the main features of active tuberculosis and a contagious state of the host.
The mechanisms of cell-autonomous elimination of M. tuberculosis by autophagy have been studied extensively in vitro and include direct microbial digestion in autophagolysosomes (26) , delivery of neo-antimicrobial peptides generated in autolysosomes to compartments harboring intracellular mycobacteria (27, 32, 50) , and an interplay of autophagy with conventional antimicrobial peptides (28) . Our previous work (32) highlighted the role of the SLR p62 in these processes, complementing the examples of other SLRs engaging an array of intracellular bacteria (31, (52) (53) (54) (55) and viruses (56) . In contrast to a preponderance of studies in vitro, autophagic control of microbes is not fully documented in vivo (34, 56) . Altered intestinal tissue and Paneth cell function has been noted in response to microbial flora and viral coinfection in an Atg16L1 hypomorph mouse model of Crohn disease, a chronic inflammatory condition (57) . In the animal model of protection against lethal Sindbis virus infection, the dominant contribution of autophagy was in preventing tissue damage independently of viral loads (56) . These observations dovetail with the aspect of our study that shows autophagic protection against excessive inflammation and necrosis in the murine model of tuberculosis. We interpret our data and reports by others (23, 24, 57, 58) as evidence that partial seeds of endogenous inflammation and predisposition to hyperreactivity exist in autophagy-deficient uninfected animals. This predisposition is in keeping with the cell-autonomous IL-1α hypersecretion shown here and eventually leads to increased pathology in infected animals. Although leukocytes from uninfected Atg5 fl/fl LysM-Cre + animals show a propensity to polarize into IL-17 cells when tested ex vivo, IL-17 has been detected in vivo only in infected animals. Thus, the elevated IL-17 response represents a product of interactions between M. tuberculosis and a host defective for autophagy in myeloid cells.
The findings that a loss of autophagy in macrophages results in increased release of IL-1α and fosters an environment in which T cells produce IL-17 link autophagy with elements of the Th17 response. The associated elevated presence of neutrophils in the lungs of Atg5 fl/fl LysM-Cre + mice infected with M. tuberculosis may be linked to increased pathology. IL-17 and neutrophils play a complex role in tuberculosis (59) and confer both positive (60) (61) (62) and negative elements of protection (63) (64) (65) . The latter aspect of the role of neutrophils in tuberculosis has been highlighted recently in patient cohort studies (66) and is compounded further by correlates between type I IFN (not addressed in our study) and different participating cells (66, 67) . The pathogenic effects of neutrophils are notably manifested during repeat exposure to mycobacterial antigens (65) and at times when a lingering Th17 response does not give way to Th1 control (64) or is not suppressed by regulatory mechanisms (63) . Our findings indicate that autophagy, when functional, curbs neutrophilic response, possibly at the time when it needs to be diminished (63) (64) (65) .
All reports thus far (6, 23-25, 58, 68) agree that autophagy plays a negative role in inflammasome activation through a variety of triggers or additional mechanisms. Autophagy suppresses the basal level of inflammasome activation by continually removing (23, 24) endogenous sources of inflammasome agonists such as ROS and mitochondrial DNA (23, 24) . Our findings with the ROS-calpain axis in IL-1α activation and findings by others regarding ROS-RLR signaling (16) expand these proinflammatory phenomena to noninflammasome pathways downstream of the accumulation of dysfunctional mitochondria and ROS in autophagy-deficient cells. Other changes with inflammatory consequences have been noted in mice with Atg5-deficient macrophages (57, 69) .
Tuberculosis has been and remains one of the main global public health hazards further augmented by the HIV co-pandemic (70) . The classical presentation of disease often is masked by the untreated HIV coinfection (70) , but in principle the majority of humans have a well-developed capacity to contain the infection, so that the majority of the world's population infected with the tubercle bacillus is asymptomatic, and only ∼10% of individuals develop active disease. This tip of the iceberg nevertheless is key to continuing the tuberculosis contagion in human populations, because active disease is necessary for the transmission of tuberculosis. We propose that autophagy plays a dual role: It both protects against the microbe and guards against host-inflicted tissue destruction and active disease. In this model autophagy curbs tuberculosis transmission by helping maintain the majority of the infected population asymptomatic. Strategies aimed at pharmacological manipulation of autophagy may diminish tuberculosis spread and may prove vital in containing the emergence of the increasingly drug-resistant tuberculosis strains.
Materials and Methods

Mice and Infection. The transgenic Atg5
fl/fl LysM-Cre + (myeloid-specific Atg5 deletion) and Atg5 fl/fl LysM-Cre − mice have been characterized previously (34) , and the autophagy defect in BMM has been documented extensively (6) . LC3-GFP knockin transgenic mice (71) and p62 −/− knockout mice (72) have been described previously. Mice were maintained under specific pathogen-free conditions. F1 progeny from Atg5 fl/fl LysM-Cre × Atg5 fl/fl crosses were genotyped for the presence (LysM-Cre + ) or absence (LysM-Cre) of the LysM-Cre allele by Transnetyx Inc. Infection studies were carried out using a murine respiratory infection model (73) (NLDL-145), CD8 (53-6.7), CD86 (GL-1), Ly6G (1A8), CD25 (PC61), MHC II (M5/ 114.15.2) (Biolegend), CD19 (eBio1D3), TCRβ (H57-597), CD3e (145-2C11), CD44 (IM7), CD4 (GK1.5), CD1d (1B1), DEC205 (205yekta), CD4 (RM4-5), CD45 (30-F11), CD3 (17A2), F4/80 (BM8), CD11b (M1/70), B220 (RA3-6B2), CD8α (53-6.7), IL-12p35 (4D10p35), IL-1α (ALF-161), MCH II (M5/114.15.2), CD25 (PC61.5) (eBioscience), and Ly6G (1a8) (BD Biosciences). Caspase 1 activity was measured by flow cytometry using the FLICA caspase 1 reagent (FAM-YVAD-FMK) (Immunochemistry Technologies). Cells were incubated with 7-AAD for viability assessment. Secreted cytokines (IL-1α, IL-1β, CXCL1, CXCL2, and IL-12p70) were measured by ELISA (R&D Systems). For cytokine secretion, murine BMM, prepared as described (32) Calmette-Guérin for 21 d and then were injected in separate footpads with 50 μL of the synthetic PPD (a mixture of five antigens: Dnak, GroEL, Rv009, Rv0569, and Rv0685) at 1.0 μg/mL in PBS or with PBS (control). DTH was assessed as described (38) by comparing swelling to a baseline value immediately after injection. Splenocytes (5.0 × 10 5 cells per well) were restimulated with the synthetic PPD adjusted for 2.0 μg/mL (Dnak and GroEL) or 4.0 μg/mL (Rv009, Rv0569, and Rv0685), and culture supernatants were assayed for IFN-γ, TNF-α, IL-4, and IL-17 secretion by ELISA (R&D Systems). (76) and were stimulated with 20 ng/mL IL-6, 5 ng/mL TGF-β, 20 ng/mL IL-1α, or 20 ng/mL IL-1β (R&D Systems) in the presence of anti-CD28 (37.51), anti-IFN-γ (R4.6A2), anti-IL-4 (11B11), and anti-IL-2 (JE56-1A12) (eBioscience). After 4 d, cells were stimulated with 1× Cell Stimulation Mixture in the presence of protein transport inhibitors for 5 h at 37°C and were analyzed by flow cytometry.
Other Experimental Procedures. Additional methods are described in SI Appendix.
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Mice were weighted twice prior to infection on days -3 and -1 for baseline. Upon infection, mice were monitored daily for survival and weighted semi-weekly. At the indicated times, mice were sacrificed by CO 2 overdose, and lungs were harvested and homogenized in 1 ml of PBS/0.05% Tween 80. For histopathological examination, lungs were insufflated with 10% neutral buffered formalin via tracheal cannulation and removed en bloc. At the same time, spleens were harvested and all organs were placed into 10% buffered formalin for further processing in histological studies. Paraffinembedded sections were stained with hematoxylin and eosin (H&E stain) or acid fast stain and evaluated by a board certified veterinary pathologist. Samples were subjected to a freeze/thaw cycle, sonicated for 30 sec, allowed to sit on ice for 30 min, centrifuged at 12,000 rpm for 10 min, supernatants collected and filtered through a 0.45 µm syringe filter and assayed for cytokines using the Luminex Multiplex System (Luminex Corp, Austin TX). Beads for cytokine quantification were from Invitrogen and used according to the manufacturer's instruction.
Cells and tissue preparation. Lungs were perfused with sterile saline in order to remove peripheral blood cells. Lungs were then minced and enzymatically (DNAse/collagenase solution) treated at 37 o C for 60 min. The digested lung tissue was then mechanically disrupted using a pestle and wire screen. Cells were then filtered over a nylon wool column to remove particulate and remaining red blood cells were lysed and cells were then centrifuged through a layer of 30% percoll to remove debris and dead cells. Spleens were homogenized in HBSS containing HEPES, L-glutamine and pen-strep (HGPG) using frosted slides. For lung homogenate, lungs were minced, homogenized, homogenate resuspended in a total volume of 1 ml PBS, pressed through a 70-mm cell strainer, centrifuged and clarified supernatant collected for analysis.
Antibodies, immunoblotting, detection assays, siRNA knockdowns and flow cytometry. Cells were washed with PBS and lysed with RIPA buffer containing protease inhibitor cocktail (Roche). Cells extracts were analyzed by standard immunoblotting techniques with antibodies to ASC (Enzo Life Science, AL177), procaspase-1 and active caspase-1 (P20) (Cell Signaling, 2225), GFP (Abcam), calpain I (Cell Signaling), p62 (Abcam) and actin (Sigma). Proteins were resolved on a 12 % SDS-polyacrylamide gels and transferred to nitrocellulose membranes. The membrane was blocked for 1h in 5% non-fat dried milk in PBS/Tween 20 (0.1%) and probed with primary antibody overnight at 4°C. After washing with PBS/Tween, the blot was probed with appropriate anti-mouse HRP-conjugated secondary antibody for 1 h at room temperature and stained with SuperSignal West Dura chemiluminescent substrate (Thermo Fisher Scientific). Actin was used as standardization control. For siRNA knockdowns, BMM were transfected by nucleoporation using Nucleofector Reagent Kit Mouse Macrophage (Amaxa/Lonza Biosystems). For murine p62 or Atg5 knockdowns, cells were transfected with siGENOME SMARTpool reagents (Dharmacon): p62: (GCATTGAAGTGGATATTGA; GACGATGACTGGACCCATT; TCGGAGGATCCCAGTGTGA; CAGCAAGCCGGGTGGGAAT); Figure 1 were analyzed by Kaplan-Meier survival analysis with the Log-Rank method, using SigmaStat version 3.0 (Systat Inc, San Jose, California). The difference between the survival curves was significant with P<0.01. All other data were analyzed using ANOVA (KaleidaGraph) or two-tailed unpaired Student's t-tests (Prism). Fig. 5F ) in the presence of (A) 50 mg/ml rapamycin (Rap) and 10 mM 3-MA after 12 h of stimulation. Data: mean ±SE; *, p<0.05; † (or no symbol) p>0.05 (t test; n≥3). fl/fl LysM-Cre -or Cre + BMM and quantification of calpain relative to actin. (G) Calpain does not colocalize with the autophagosomal marker LC3. Confocal microscopy image of endogenous calpain I (Capn1) and immunofluorescently (anti-GFP) labeled GFP-LC3 in BMM from GFP-LC3 knock-in mice. Scale bar, 10 µm. Graph, Pearson's colocalization coefficient (n=3) between calpain I and LC3 (note the negative value). Data, mean ±SE, *p<0.05, † p>0.05 (t test; n≥3).
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